| Closed |
SWOG-427 |
Cytosine Arabinoside (NSC-63878) in Acute Leukemia in Adults |
7/1/1967 |
6/9/1969 |
2% |
|
|
| Closed |
S0116 |
D1/3-MAGE-3 His Protein + SB-AS02B/Selected Stage IV, M1a or M1b |
9/15/2002 |
2/15/2004 |
2% |
|
|
| Open |
S1609 |
DART |
1/13/2017 |
|
98% |
|
|
| Closed |
S0711 |
Dasatinib in patients with impaired hepatic function |
10/15/2008 |
|
100% |
|
|
| Open |
S1904 |
Decision Support Tool |
9/1/2020 |
|
99% |
|
|
| Closed |
S1512 |
Desmoplastic study |
10/20/2016 |
|
100% |
|
|
| Closed |
S9702 |
Detection of malignant cells in marrow and PBPC products |
10/1/1997 |
7/15/1999 |
4% |
|
|
| Closed |
S0345 |
DFSP |
5/15/2004 |
12/15/2006 |
20% |
|
Published
|
| Closed |
SWOG-8065 |
DHAD in Adults with Metastatic Malignant Melanoma |
7/2/1980 |
10/18/1983 |
|
|
Published
|
| Closed |
SWOG-9110 |
Didemnin B in CNS tumors |
11/1/1991 |
11/15/1993 |
100% |
|
Published
|
| Closed |
S1916 |
Digital Medicine for Opioid Pain Control |
6/11/2019 |
|
3% |
|
|
| Closed |
SWOG-8842 |
Dihydroxyazacytidine in Malignant Mesothelioma, Phase II |
12/15/1989 |
11/15/1992 |
100% |
|
Published
|
| Open |
S1703 |
Disease Monitoring Study |
7/16/2018 |
|
47% |
|
|
| Closed |
SWOG-8859 (INT-0110) |
DNA Flow Cytometric Analysis in Patients with Prostate Cancer: A Companion Protocol to SWOG-8890 (INT-0109) |
4/15/1990 |
1/1/1992 |
|
|
|
| Closed |
S0429 |
Docetaxel and Cetuximab Chemoradiation in Stage III NSCLC |
4/1/2006 |
8/15/2009 |
40% |
|
Published
|
| Closed |
S1600 |
Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes |
2/21/2019 |
10/20/2023 |
100% |
|
|
| Closed |
SWOG-8530 |
Efficacy of Prednisone in Refractory and Relapsing Multiple Myeloma and Measurement of Glucocorticoid Receptors |
|
1/1/1990 |
100% |
|
Published
|
| Closed |
S1013 |
EGFR Skin Toxicity Validation |
11/15/2011 |
10/1/2016 |
94% |
|
|
| Closed |
S0114 |
EGFRvIII Peptide Vaccine |
11/1/2002 |
6/1/2006 |
47% |
|
|
| Closed |
S9918 |
Elderly AML |
2/1/2000 |
3/15/2001 |
29% |
|
|
